» Articles » PMID: 21105916

Negative Methacholine Challenge Tests in Subjects Who Report Physician-diagnosed Asthma

Overview
Date 2010 Nov 26
PMID 21105916
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The frequency of adults reporting a history of asthma is rising. However, it is unclear whether this increased prevalence accurately demonstrates a rising trend or if it reflects an overall increase in asthma awareness.

Objective: To determine the frequency of negative methacholine bronchoprovocation tests in adults who report physician-diagnosed asthma and to explore the clinical characteristics of subjects with negative tests.

Methods: Data from methacholine challenge, spirometry, and physician assessment were analysed from 304 adults who reported physician-diagnosed asthma and responded to community-based advertising for asthma research studies. The clinical characteristics of methacholine-positive and -negative subjects were compared and a predictive model was tested to identify those characteristics associated with a negative test.

Results: Of the 304 subjects tested, 83 (27%) had a negative methacholine test. A negative test was positively associated with an adult-onset of symptoms (P<0.001), normal forced expiratory volume in 1 s (P<0.001), and having no history of exacerbation requiring oral steroids (P=0.03). Over half (60%) of those with a negative test reported weekly asthma-like symptoms (cough, dyspnoea, chest tightness, or wheeze), while 39% reported emergency department visits for asthma-like symptoms.

Conclusions And Clinical Relevance: A sizeable percentage of subjects who report physician-diagnosed asthma have a negative methacholine challenge test. These subjects are characterized by diagnosis of asthma as an adult and by normal or near normal spirometry. Caution should be exercised in the assessment and diagnosis of adults presenting with asthma-like symptoms, because they may not have asthma. Further diagnostic studies, including bronchoprovocation testing, are warranted in this patient group, especially if their spirometry is normal.

Citing Articles

Pulmonary Function Tests in Thunderstorm-associated Respiratory Symptoms: A Cross-sectional Study.

Shoushtari M, Afrakhteh S, Borsi S, Raji H, Idani E Iran J Med Sci. 2024; 49(1):40-45.

PMID: 38322159 PMC: 10839138. DOI: 10.30476/ijms.2023.96337.2784.


WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. .

Rouadi P, Idriss S, Bousquet J, Laidlaw T, Azar C, Al-Ahmad M World Allergy Organ J. 2022; 15(5):100649.

PMID: 35600836 PMC: 9117692. DOI: 10.1016/j.waojou.2022.100649.


Real-life impact of COVID-19 pandemic lockdown on the management of pediatric and adult asthma: A survey by the EAACI Asthma Section.

Eguiluz-Gracia I, van den Berge M, Boccabella C, Bonini M, Caruso C, Couto M Allergy. 2021; 76(9):2776-2784.

PMID: 33772815 PMC: 8250685. DOI: 10.1111/all.14831.


Asthma: A Loss of Post-natal Homeostatic Control of Airways Smooth Muscle With Regression Toward a Pre-natal State.

Anthracopoulos M, Everard M Front Pediatr. 2020; 8:95.

PMID: 32373557 PMC: 7176812. DOI: 10.3389/fped.2020.00095.


Targeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money.

Al Said A, Cushen B, Costello R Ther Adv Chronic Dis. 2017; 8(2-3):31-45.

PMID: 28348726 PMC: 5354131. DOI: 10.1177/2040622317690494.


References
1.
Moorman J, Anne Rudd R, Johnson C, King M, Minor P, Bailey C . National surveillance for asthma--United States, 1980-2004. MMWR Surveill Summ. 2007; 56(8):1-54. View

2.
Prieto L, Lopez V, Llusar R, Rojas R, Marin J . Differences in the response to methacholine between the tidal breathing and dosimeter methods: influence of the dose of bronchoconstrictor agent delivered to the mouth. Chest. 2008; 134(4):699-703. DOI: 10.1378/chest.08-0093. View

3.
LindenSmith J, Morrison D, Deveau C, Hernandez P . Overdiagnosis of asthma in the community. Can Respir J. 2004; 11(2):111-6. DOI: 10.1155/2004/276493. View

4.
Ulrik C . Factors associated with increased bronchial responsiveness in adolescents and young adults: the importance of adjustment for prechallenge FEV1. J Allergy Clin Immunol. 1996; 97(3):761-7. DOI: 10.1016/s0091-6749(96)80153-9. View

5.
Green M, Mead J, Turner J . Variability of maximum expiratory flow-volume curves. J Appl Physiol. 1974; 37(1):67-74. DOI: 10.1152/jappl.1974.37.1.67. View